Skip to content

Clinical trials

Completed Phase 3 Rare Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Phase: Phase 3 Status: Completed Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20121
20131
20141
20152
20161
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)24
Amgen4
National Institute of Neurological Disorders and Stroke (NINDS)4
FDA Office of Orphan Products Development3
National Institute of Allergy and Infectious Diseases (NIAID)2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Ultragenyx Pharmaceutical Inc2
AO GENERIUM1
Assistance Publique - Hôpitaux de Paris1
Brigham and Women's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases53
Mental Disorders13
Neurologic Manifestations13
Communicable Diseases10
Immune System Diseases10
Genetic Diseases, Inborn5
Respiratory Tract Diseases5
Virus Diseases5
Bacterial Infections4
Cystinosis4

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.